Your browser doesn't support javascript.
loading
A novel BET bromodomain inhibitor, RVX-208, shows reduction of atherosclerosis in hyperlipidemic ApoE deficient mice.
Jahagirdar, Ravi; Zhang, Haiyan; Azhar, Salman; Tobin, Jennifer; Attwell, Sarah; Yu, Raymond; Wu, Jin; McLure, Kevin G; Hansen, Henrik C; Wagner, Gregory S; Young, Peter R; Srivastava, Rai Ajit K; Wong, Norman C W; Johansson, Jan.
Affiliation
  • Jahagirdar R; Resverlogix Corp., Calgary, Canada. Electronic address: ravi@resverlogix.com.
  • Zhang H; VA Palo Alto Health Care System, Palo Alto, USA.
  • Azhar S; VA Palo Alto Health Care System, Palo Alto, USA.
  • Tobin J; Resverlogix Corp., Calgary, Canada.
  • Attwell S; Resverlogix Corp., Calgary, Canada.
  • Yu R; Resverlogix Corp., Calgary, Canada.
  • Wu J; Resverlogix Corp., Calgary, Canada.
  • McLure KG; Resverlogix Corp., Calgary, Canada.
  • Hansen HC; Resverlogix Corp., Calgary, Canada.
  • Wagner GS; Resverlogix Corp., Calgary, Canada.
  • Young PR; Resverlogix Corp., Calgary, Canada.
  • Srivastava RA; Integrated Pharma Solutions, Philadelphia, USA.
  • Wong NC; Resverlogix Corp., Calgary, Canada.
  • Johansson J; Resverlogix Corp., Calgary, Canada.
Atherosclerosis ; 236(1): 91-100, 2014 Sep.
Article in En | MEDLINE | ID: mdl-25016363

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Aortic Diseases / Quinazolines / Atherosclerosis / Betaine-Homocysteine S-Methyltransferase / Hyperlipidemias Type of study: Etiology_studies Language: En Journal: Atherosclerosis Year: 2014 Document type: Article Country of publication: Irlanda

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Aortic Diseases / Quinazolines / Atherosclerosis / Betaine-Homocysteine S-Methyltransferase / Hyperlipidemias Type of study: Etiology_studies Language: En Journal: Atherosclerosis Year: 2014 Document type: Article Country of publication: Irlanda